- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03693469
Virtual Reality vs. Standard-of-Care for Comfort During Immunizations in Children
A Pragmatic Randomized Controlled Trial of Virtual Reality vs. Standard-of-Care for Comfort During Immunizations in Children
Children need routine immunizations which can be a painful procedure associated with pain and anxiety. This is particularly true of children visiting the children's hospital to visit relatives during flu season. No topical anesthetic or oral analgesia is commonly used.
Virtual Reality (VR) is an immersive experience using sight, sound, and position sense. Using VR may enhance distraction during the painful procedure and may reduce attention to pain.
This study will randomize children (6 - 16 years old) to receive Virtual Reality or standard of care while receiving immunizations. Investigators will measure pain, anxiety and satisfaction.
Study Overview
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
British Columbia
-
Vancouver, British Columbia, Canada, V6H 3N1
- Recruiting
- BC Children's Hospital
-
Contact:
- Ran D Goldman, MD
- Phone Number: 604-875-2000
- Email: rgoldman@cw.bc.ca
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Children age 6 to 16 years
- Patients arriving to the immunization clinic for immunization.
- Parents will sign a consent form and children will sign an assent form
Exclusion Criteria:
- Children with conditions that may prohibit participation or evaluation of the procedure (such as developmental delay)
- Facial features or injury prohibiting wearing the VR goggles
- VR system may interfere with immunization
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control (Standard-of-Care)
Participants are distracted with Standard-of-Care by doctors, nurses, nurse practitioners, child life specialists and/or parents.
|
|
|
Experimental: Virtual Reality
Participants are distracted by wearing the virtual reality headset and watching a roller coaster app during immunization.
|
Participants wear a Virtual Reality headset that consists of a ASUS phone and a VOX+ Z3 3D Virtual Reality Headset.
The phone runs the VR Roller Coaster app to produce the virtual environment.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain using the Faces Pain Scale - Revised
Time Frame: Pain is reported by children immediately following completion of the immunization (within two minutes post-immunization). This scale should take less than one minute to complete.
|
Level of pain as reported by children using Faces Pain Scale - Revised.
The scale includes six faces that represent progressively more intense features of pain.
Children point to the face that best represents their current level of pain.
The minimum score is 0 (representing least pain) and the maximum score is 10 (representing greater pain).
The scale increase in increments of 2.
|
Pain is reported by children immediately following completion of the immunization (within two minutes post-immunization). This scale should take less than one minute to complete.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Anxiety using the Venham Situational Anxiety Score
Time Frame: Anxiety is reported by children immediately following completion of the immunization (within two minutes post-immunization). This scale should take less than one minute to complete.
|
Level of Situational Anxiety as reported by children using the Venham Situational Anxiety Score.
This scale includes 8 sets of 2 images of children which represent differing levels of anxiety.
Children point to the child that best represents them in that instance.
In each set of 2 images of children, one represents greater anxiety (scored as 1) and one represents lesser anxiety (scored as 0).
The points from each set of images are totaled.
The minimum score is 0 (least anxious) and maximum score is 8 (most anxious).
|
Anxiety is reported by children immediately following completion of the immunization (within two minutes post-immunization). This scale should take less than one minute to complete.
|
|
Patient Satisfaction determined by Global Rating Scale
Time Frame: Satisfaction question is reported by children immediately following completion of the immunization (within 5 minutes post immunization)
|
Satisfaction from the procedure is determined by asking 4 questions on a global rating scale.
This scale goes from 0-10 where 0 represents "not very much" and 10 represents "very much."
Questions are developed from previous virtual reality research.
"Overall, how satisfied are you with pain management during plastic surgery?" "Overall, how satisfied are you with anxiety management during plastic surgery?" "To what extent did you feel like you went into the virtual world?" "How much fun did you have while playing in the virtual world?"
These questions will be analyzed individually not summed.
|
Satisfaction question is reported by children immediately following completion of the immunization (within 5 minutes post immunization)
|
|
Medication Dose
Time Frame: These will be recorded during the procedure and immediately following the procedure using the patient chart
|
How much topical or local anesthetics are used and when they are used (24 hour time); how much sedatives are used and when they are used (24 hour time); how much analgesics are used and when they are used (24 hour time).
|
These will be recorded during the procedure and immediately following the procedure using the patient chart
|
|
Length of time of procedure
Time Frame: This will be documented during the procedure
|
Time in minutes from readiness for procedure (availability of child, staff and equipment) until completion of procedure (healthcare practitioner does not need to touch the patient anymore)
|
This will be documented during the procedure
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ran Goldman, MD, University of British Columbia
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- H18-01851
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vaccination
-
University of TorontoWholehealth Pharmacy PartnersNot yet recruitingVaccination | Vaccination Reaction | Vaccination Pain | Vaccination PharmacyCanada
-
University of Massachusetts, WorcesterRecruiting
-
University of IowaNational Institute on Aging (NIA)CompletedVaccination | Vaccination Hesitancy | Vaccination Promotion | Psychological AspectsUnited States
-
University of Roma La SapienzaCompletedVaccination Failure | Vaccination Adverse Events | Specific Antibody ResponseItaly
-
Xiamen UniversityXiamen Center for Disease Control and PreventionNot yet recruitingHPV Vaccination Rates | HPV Vaccine Awareness | HPV Vaccination Intention
-
University of PennsylvaniaCompletedVaccine Refusal | Vaccination Hesitancy | Human Papillomavirus VaccinationUnited States
-
National Cancer Institute (NCI)CompletedHPV16 Anitbody Levels Post Vaccination | HPV18 Antibody Levels Post VaccinationUganda
-
Université de Reims Champagne-ArdenneRecruiting
-
University of EssexUniversity of Southern California; Kingston University; Department of Health...Completed
-
China National Biotec Group Company LimitedPeking University; Beijing Institute of Biological Products Co Ltd.; Sichuan... and other collaboratorsCompleted
Clinical Trials on Virtual Reality
-
Institut National de la Santé Et de la Recherche...RecruitingSchizophrenia | Bipolar DisorderFrance
-
Eskisehir Osmangazi UniversityNot yet recruiting
-
The University of Hong KongCompleted
-
University of PennsylvaniaRecruiting
-
Istanbul University - CerrahpasaCompletedCancer | AnxietyTurkey
-
Cihat OzyılmazCompletedChild | Anxiety | FearTurkey
-
National University of MalaysiaRecruitingPleural EffusionMalaysia
-
Stanford UniversityTerminatedConversion Disorder | Non-epileptic Seizures | Functional Neurological Disorder | Functional Movement Disorder | Psychogenic Movement DisorderUnited States
-
University of WashingtonNational Institutes of Health (NIH); University of Texas; National Institute...Completed
-
Children's Hospital Los AngelesNot yet recruitingProcedural Pain | Procedural Anxiety